Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BLDG Active is a consumer health company focused on bringing medical-grade wound care technology to the everyday athlete and outdoor enthusiast. The company's primary product line, Active Skin Repair, utilizes Hypochlorous acid (HOCl), a molecule naturally produced by the human body's white blood cells to combat inflammation and infection. Their formulations are non-toxic, antibiotic-free, and biodegradable, making them a safe alternative to traditional petroleum-based ointments. BLDG Active is a certified B Corp and is headquartered in California, emphasizing environmental sustainability alongside clinical efficacy. The company's products are widely used for treating minor wounds, burns, rashes, and other skin irritations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BLDG Active.